Home / Venlafaxine / Canada
CA ATC N06AX16 · updated 2 Nov 2026
Venlafaxine shortage in Canada
Is there a Venlafaxine shortage in Canada?
Yes. As of 2 Nov 2026, 11 Venlafaxine products are reported short in Canada, the first since 26 Jul 2022. The company estimate for the return is 20 Nov 2026 (latest 31 Jan 2027). Main reason: manufacturing problem.
Also short in France, Italy, Spain, Ireland, Austria, Belgium, Czechia, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-VENLAFAXINE XR (500 BTL) | APOTEX INC | 26 Jul 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-VENLAFAXINE XR (100 BTL) | APOTEX INC | 13 Dec 2022 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-VENLAFAXINE XR (100 BTL) | APOTEX INC | 18 Apr 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-VENLAFAXINE XR (500 BTL) | APOTEX INC | 9 May 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-VENLAFAXINE XR (500 BTL) | APOTEX INC | 6 Jun 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-VENLAFAXINE XR (100 BTL) | APOTEX INC | 20 Jun 2023 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-VENLAFAXINE XR (100's Bottle) | SUN PHARMA CANADA INC | 13 Apr 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-VENLAFAXINE XR (500's Bottle) | SUN PHARMA CANADA INC | 19 May 2026 | 18 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MINT-VENLAFAXINE XR (100 Count bottles) | MINT PHARMACEUTICALS INC | 28 Jul 2026 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MINT-VENLAFAXINE XR (500 count bottles) | MINT PHARMACEUTICALS INC | 28 Jul 2026 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MINT-VENLAFAXINE XR (500 count bottles) | MINT PHARMACEUTICALS INC | 28 Jul 2026 | 31 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.